Plus Chemicals SA

Switzerland

 
Total IP 20
Total IP Rank # 74,270
IP Activity Score 0/5.0    0
IP Activity Rank # 1,658,319

Patents

Trademarks

1 0
0 0
19 0
0
 
Last Patent 2015 - Solid state forms of cabazitaxel...
First Patent 1996 - Selective process for the deacyl...

Latest Inventions, Goods, Services

2014 Invention Solid state forms of cabazitaxel and processes for preparation thereof. The invention relates to...
2013 Invention Solid state forms of cabazitaxel and processes for preparation thereof. The invention relates to ...
2012 Invention Processes and intermediates for preparing pralatrexate. Processes for preparing and purifying Pra...
2011 Invention Solid state forms of dabigatran etexilate, dabigatran etexilate mesylate and processes for prepar...
Invention Solid state forms of ixabepilone. Crystalline forms of Ixabepilone are described in the present a...
2010 Invention Process for the preparation of n-protected-decylaminoethanal. Compounds useful in the preparation...
Invention Polymorphs of bendamustine hcl and processes for preparation thereof. Novel polymorphs of Bendamu...
Invention Polymorphs of fluticasone furoate and processes for preparation thereof. The present invention pr...
2009 Invention Polymorphs of vorinostat and vorinostat potassium salt and process for preparation thereof. Cryst...
Invention Polymorphs of fluticasone furoate and process for preparation thereof. Provided are polymorphs of...
Invention Crystalline forms of erlotinib base and erlotinib hcl. The preparation of crystalline Erlotinib b...
Invention Salts of (r)-5-(2-phenylsulphonylethenyl)-3-(n- methylpyrrolidin-2-ylmethyl)-1h-indole, 5-bromo-3...
Invention Method of manufacturing of 7-ethyl-10-hydroxycamptothecin. The method of manufacturing of 7-ethyl...
Invention Process for the preparation of capecitabine. The present application relates to an improved proce...
2008 Invention Process for the preparation of crystalline forms a, b and pure crystalline form a of erlotinib hc...
Invention Processes for the preparation of crystalline forms a, b and pure crystalline form a of erlotinib ...
Invention Stable formulations of crystalline erlotinib hcl. The present invention provides stable formulati...
Invention Crystalline forms of erlotinib hcl and formulations thereof. The invention provides a novel cryst...
Invention Amorphous erlotinib, processes for the preparation thereof, and processes to prepare additional f...
Invention Process for preparing 5-bromo-3-[(r)-1-methyl-pyrrolidin-2-ylmethyl]-1h-indole. The invention en...
Invention A process for preparing 5-bromo-3-[(r)-1-methyl-pyrrolidin-2-ylmethyl]-1h-indole. The invention e...
Invention Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydr...
2004 Invention Method of manufacturing of 7-ethyl-10-[4-(1-piperidino)-1- piperidino]- carbonyloxy- camptothecin...
2001 Invention A process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities. A p...
2000 Invention Hmg-coa reductase inhibitor preparation process. The invention provides a simple and selective me...
1999 Invention Nitrogen feed in statin fermentation. A fermentation process is disclosed for producing an HMG-Co...
1997 Invention Selective process for the deacylation of acylated compounds. The invention provides a simple and...
1996 Invention Selective process for the deacylation of acylated compounds. The invention provides a simple and ...